Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Ureterolysis: technique, indications].
Loison G, Almeras C, Chartier-Kastler E. Loison G, et al. Ann Urol (Paris). 2005 Feb;39(1):1-9. doi: 10.1016/j.anuro.2004.12.001. Ann Urol (Paris). 2005. PMID: 15830549 Review. French.
Performance of systematic, MRI-targeted biopsies alone or in combination for the prediction of unfavourable disease in MRI-positive low-risk prostate cancer patients eligible for active surveillance.
Ploussard G, Beauval JB, Lesourd M, Almeras C, Assoun J, Aziza R, Gautier JR, Loison G, Portalez D, Salin A, Tollon C, Soulié M, Malavaud B, Roumiguié M. Ploussard G, et al. Among authors: loison g. World J Urol. 2020 Mar;38(3):663-671. doi: 10.1007/s00345-019-02848-x. Epub 2019 Jun 13. World J Urol. 2020. PMID: 31197523
Added Value of Concomitant Systematic and Fusion Targeted Biopsies for Grade Group Prediction Based on Radical Prostatectomy Final Pathology on Positive Magnetic Resonance Imaging.
Ploussard G, Beauval JB, Lesourd M, Almeras C, Assoun J, Aziza R, Gautier JR, Loison G, Portalez D, Salin A, Tollon C, Soulié M, Malavaud B, Roumiguié M. Ploussard G, et al. Among authors: loison g. J Urol. 2019 Dec;202(6):1182-1187. doi: 10.1097/JU.0000000000000418. Epub 2019 Jun 27. J Urol. 2019. PMID: 31246548
Decreased accuracy of the prostate cancer EAU risk group classification in the era of imaging-guided diagnostic pathway: proposal for a new classification based on MRI-targeted biopsies and early oncologic outcomes after surgery.
Ploussard G, Manceau C, Beauval JB, Lesourd M, Almeras C, Gautier JR, Loison G, Salin A, Soulié M, Tollon C, Malavaud B, Roumiguié M. Ploussard G, et al. Among authors: loison g. World J Urol. 2020 Oct;38(10):2493-2500. doi: 10.1007/s00345-019-03053-6. Epub 2019 Dec 14. World J Urol. 2020. PMID: 31838560
Impact of MRI and Targeted Biopsies on Eligibility and Disease Reclassification in MRI-positive Candidates for Active Surveillance on Systematic Biopsies.
Ploussard G, Beauval JB, Lesourd M, Almeras C, Assoun J, Aziza R, Gautier JR, Loison G, Portalez D, Salin A, Tollon C, Soulié M, Malavaud B, Roumiguié M. Ploussard G, et al. Among authors: loison g. Urology. 2020 Mar;137:126-132. doi: 10.1016/j.urology.2019.10.039. Epub 2019 Dec 30. Urology. 2020. PMID: 31899229
Improvement of the intermediate risk prostate cancer sub-classification by integrating MRI and fusion biopsy features.
Roumiguie M, Lesourd M, Zgheib J, Tollon C, Salin A, Alméras C, Doumerc N, Thoulouzan M, Soulié M, Gautier JR, Loison G, Assoun J, Vacher A, Aziza R, Malavaud B, Beauval JB, Ploussard G. Roumiguie M, et al. Among authors: loison g. Urol Oncol. 2020 May;38(5):386-392. doi: 10.1016/j.urolonc.2019.12.018. Epub 2020 Jan 13. Urol Oncol. 2020. PMID: 31948932
Intercenter reproducibility of software-based fusion biopsies for grade group prediction when targeting suspicious MRI lesions.
Manceau C, Roumiguié M, Lesourd M, Beauval JB, Almeras C, Aziza R, Gautier JR, Loison G, Meyrignac O, Salin A, Tollon C, Soulié M, Malavaud B, Ploussard G. Manceau C, et al. Among authors: loison g. Urol Oncol. 2020 Sep;38(9):734.e11-734.e17. doi: 10.1016/j.urolonc.2020.03.023. Epub 2020 Apr 17. Urol Oncol. 2020. PMID: 32312641
73 results